CatalystPit

ANIPANI PHARMACEUTICALS INC

Last close $72.65 · 2026-09-30
RECENT INSIDER TRADES
  • 2026-09-30 · CAREY STEPHEN P. (SVP & CFO) · SELL
  • 2026-09-16 · Lalwani Nikhil (PRESIDENT & CEO) · SELL
  • 2026-09-14 · Cook Meredith (SR. VP, GENERAL COUNSEL & SEC.) · SELL
  • 2026-09-14 · Thoma Jeanne (Director) · SELL
  • 2026-09-01 · CAREY STEPHEN P. (SVP & CFO) · SELL
INSTITUTIONAL OWNERSHIP
Institutional holders327
Shares held27,936,570
Value$2.15B
As of quarter end2026-06-30
RECENT NEWS
  • ANI Pharmaceuticals to present fluocinolone acetonide implant trial data at AAO 2026
  • ANI Pharmaceuticals: Cortrophin's Q4 Test, With Generics Funding The Build
  • ANI Pharmaceuticals wins FDA approval for generic Everolimus tablets for oral suspension
  • Ani Pharmaceuticals executive Meredith Cook sells $35,395 in stock
  • Ani Pharmaceuticals director Thoma sells $71,530 in shares
CatalystPit
FeaturesComing soonPricingComing soonPrivacyTermsDisclaimerAffiliate TermsContact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS
ANI PHARMACEUTICALS INC (ANIP) · Stock Price, Insider Trades, Institutional Holdings · CatalystPit